- Home
- INVA vs CSWC Comparison
INVA vs CSWC Comparison
Compare INVA & CSWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- CSWC
- Stock Information
- Founded
- INVA 1996
- CSWC 1961
- Country
- INVA United States
- CSWC United States
- Employees
- INVA N/A
- CSWC N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- CSWC Textiles
- Sector
- INVA Health Care
- CSWC Consumer Discretionary
- Exchange
- INVA Nasdaq
- CSWC Nasdaq
- Market Cap
- INVA 1.1B
- CSWC 1.2B
- IPO Year
- INVA 2004
- CSWC N/A
- Fundamental
- Price
- INVA $21.98
- CSWC $21.59
- Analyst Decision
- INVA Buy
- CSWC Buy
- Analyst Count
- INVA 5
- CSWC 5
- Target Price
- INVA $36.60
- CSWC $23.50
- AVG Volume (30 Days)
- INVA 903.8K
- CSWC 670.3K
- Earning Date
- INVA 11-05-2025
- CSWC 11-03-2025
- Dividend Yield
- INVA N/A
- CSWC 11.89%
- EPS Growth
- INVA 53.96
- CSWC N/A
- EPS
- INVA 1.52
- CSWC 1.62
- Revenue
- INVA $388,521,000.00
- CSWC $217,271,000.00
- Revenue This Year
- INVA $7.98
- CSWC $14.60
- Revenue Next Year
- INVA $11.60
- CSWC $10.75
- P/E Ratio
- INVA $13.96
- CSWC $13.23
- Revenue Growth
- INVA 10.14
- CSWC 11.39
- 52 Week Low
- INVA $16.52
- CSWC $17.46
- 52 Week High
- INVA $22.76
- CSWC $23.86
- Technical
- Relative Strength Index (RSI)
- INVA 69.26
- CSWC 63.16
- Support Level
- INVA $20.68
- CSWC $20.35
- Resistance Level
- INVA $22.48
- CSWC $21.07
- Average True Range (ATR)
- INVA 0.69
- CSWC 0.39
- MACD
- INVA -0.01
- CSWC 0.13
- Stochastic Oscillator
- INVA 70.46
- CSWC 95.27
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About CSWC Capital Southwest Corporation
Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.